accountPfizer Inc (NYSE: PFE) had their neutral rating reiterated by equities research analysts at Zacks Investment Research in a research note issued to investors
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Inc (PFE) Given “Neutral” Rating by Zacks Investment Research Analysts
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account